| Abram Clint Dalley, LPC | |
|
1664 S Dixie Dr Ste E102, St George, UT 84770-7329 | |
| (435) 703-9647 | |
| (435) 703-6003 |
| Full Name | Abram Clint Dalley |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 1664 S Dixie Dr Ste E102, St George, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639454812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 294292-6004 (* (Not Available)) | Secondary |
| 101YP2500X | Counselor - Professional | 294292-6004 (* (Not Available)) | Primary |
| Entity Name | Alberto Souza Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972141588 PECOS PAC ID: 1254766371 Enrollment ID: O20200120000856 |
News Archive
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital
ViroPharma Incorporated today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®. The Ryze Above program was created for HAE patients prescribed Cinryze, the first and only drug specifically approved to help prevent swelling and/or painful attacks in teenagers and adults with HAE.
In a first step toward future human therapies, researchers at The Saban Research Institute of Children's Hospital Los Angeles have shown that esophageal tissue can be grown in vivo from both human and mouse cells. The study has been published online in the journal Tissue Engineering, Part A.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abram Clint Dalley, LPC 1664 S Dixie Dr Ste E102, St George, UT 84770-7329 Ph: (435) 703-9647 | Abram Clint Dalley, LPC 1664 S Dixie Dr Ste E102, St George, UT 84770-7329 Ph: (435) 703-9647 |
News Archive
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital
ViroPharma Incorporated today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®. The Ryze Above program was created for HAE patients prescribed Cinryze, the first and only drug specifically approved to help prevent swelling and/or painful attacks in teenagers and adults with HAE.
In a first step toward future human therapies, researchers at The Saban Research Institute of Children's Hospital Los Angeles have shown that esophageal tissue can be grown in vivo from both human and mouse cells. The study has been published online in the journal Tissue Engineering, Part A.
› Verified 7 days ago
Lukas Hildebrandt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1067 E Tabernacle St Ste 7, St George, UT 84770 Phone: 801-255-5131 | |
Jan Hadlock, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1492 S Silicon Way Ste A, St George, UT 84770 Phone: 435-275-8911 | |
Andrew J Weibert, Counselor Medicare: Not Enrolled in Medicare Practice Location: 225 N Bluff St Ste 5, St George, UT 84770 Phone: 435-229-9177 | |
Jason Reynolds, Counselor Medicare: Not Enrolled in Medicare Practice Location: 348 E 600 S, St George, UT 84770 Phone: 435-705-7574 | |
Sarah Cowley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 474 W 200 N, Suite 300, St George, UT 84770 Phone: 435-634-5621 Fax: 435-986-8700 | |
Kiley Shelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1067 E Tabernacle St, Suite 7, St George, UT 84770 Phone: 801-255-5131 Fax: 801-255-5131 | |
Samantha Montag, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1492 S Silicon Way Ste A, St George, UT 84770 Phone: 435-275-8911 |